These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 9522626)
1. [The role of abciximab in the prevention of the acute thrombotic complications of coronary angioplasty]. Mesquita A; Baptista J; Almeida M; Ferreira J; Machado F; Palos L; Silva A; Seabra-Gomes R Rev Port Cardiol; 1997 Dec; 16(12):1031-5. PubMed ID: 9522626 [No Abstract] [Full Text] [Related]
2. "Rescue" abciximab for complicated percutaneous transluminal coronary angioplasty. Garbarz E; Farah B; Vuillemenot A; André F; Angioï M; Machecourt J; Bassand JP; Wolf JE; Danchin N; Prendergast B; Iung B; Vahanian A Am J Cardiol; 1998 Sep; 82(6):800-3, A9. PubMed ID: 9761094 [TBL] [Abstract][Full Text] [Related]
3. Double vessel occlusions after balloon angioplasty treated by stenting and subsequently by abciximab infusion. Bertrand OF; Meerkin D; de Guise P; Crépeau J; Bourassa MG Can J Cardiol; 2000 Jan; 16(1):83-5. PubMed ID: 10653937 [TBL] [Abstract][Full Text] [Related]
4. On the use of abciximab in percutaneous coronary intervention. Iversen AZ Dan Med Bull; 2011 Aug; 58(8):B4312. PubMed ID: 21827726 [No Abstract] [Full Text] [Related]
5. "Rescue" utilization of abciximab for the dissolution of coronary thrombus developing as a complication of coronary angioplasty. Muhlestein JB; Karagounis LA; Treehan S; Anderson JL J Am Coll Cardiol; 1997 Dec; 30(7):1729-34. PubMed ID: 9385900 [TBL] [Abstract][Full Text] [Related]
6. Platelets and vascular thrombosis. Harker LA N Engl J Med; 1994 Apr; 330(14):1006-7. PubMed ID: 8121441 [No Abstract] [Full Text] [Related]
7. Simultaneous thromboses of two coronary arteries in a heavy smoker woman: a singular case of acute myocardial infarction. Colantonio R; Rotolo F; Monti F; Boggi A; Serdoz R Minerva Cardioangiol; 2012 Aug; 60(4):448-50. PubMed ID: 22858925 [No Abstract] [Full Text] [Related]
8. Assessment of coronary angiograms prior to and after treatment with abciximab, and the outcome of angioplasty in refractory unstable angina patients. Angiographic results from the CAPTURE trial. van den Brand M; Laarman GJ; Steg PG; De Scheerder I; Heyndrickx G; Beatt K; Kootstra J; Simoons ML Eur Heart J; 1999 Nov; 20(21):1572-8. PubMed ID: 10529325 [TBL] [Abstract][Full Text] [Related]
9. Instant dissolution of intracoronary thrombus by abciximab. Lee CH; Ho KT; Tan HC Int J Cardiol; 2005 Sep; 104(1):102-3. PubMed ID: 16137518 [TBL] [Abstract][Full Text] [Related]
10. Frequency and efficacy of glycoprotein IIb/IIIa therapy for treatment of threatened or acute vessel closure in 1332 patients undergoing percutaneous transluminal coronary angioplasty. Haase KK; Mahrholdt H; Schröder S; Baumbach A; Oberhoff M; Herdeg C; Karsch KR Am Heart J; 1999 Feb; 137(2):234-40. PubMed ID: 9924156 [TBL] [Abstract][Full Text] [Related]
12. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. An industry perspective on health economics studies. Anderson KM; Bala MV; Weisman HF Am Heart J; 1999 May; 137(5):S129-32. PubMed ID: 10220615 [No Abstract] [Full Text] [Related]
13. Benefit of bolus-only platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: insights from the very early outcomes in the Evaluation of 7E3 for the Prevention of Ischemic Complications (EPIC) trial. Marmur JD; Mitre CA; Barnathan E; Cavusoglu E Am Heart J; 2006 Nov; 152(5):876-81. PubMed ID: 17070148 [TBL] [Abstract][Full Text] [Related]
14. Safety, inhibition of platelet aggregation and pharmacokinetics of Fab'2 fragments of the anti-glycoprotein IIb-IIIa monoclonal antibody FRaMon in high-risk coronary angioplasty. Mazurov AV; Pevzner DV; Antonova OA; Byzova TV; Khaspekova SG; Semenov AV; Vlasik TN; Samko AN; Staroverov II; Ruda MY Platelets; 2002 Dec; 13(8):465-77. PubMed ID: 12487780 [TBL] [Abstract][Full Text] [Related]
15. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators. Lincoff AM; Califf RM; Moliterno DJ; Ellis SG; Ducas J; Kramer JH; Kleiman NS; Cohen EA; Booth JE; Sapp SK; Cabot CF; Topol EJ N Engl J Med; 1999 Jul; 341(5):319-27. PubMed ID: 10423466 [TBL] [Abstract][Full Text] [Related]
16. Is conventional antiplatelet therapy for the prevention of coronary stent thrombosis always safe? A case report of a patient with polycythemia vera. Zavalloni D; Marsico F; Milone F; Presbitero P Ital Heart J; 2004 Feb; 5(2):163-6. PubMed ID: 15086149 [TBL] [Abstract][Full Text] [Related]
17. Prospective randomised study to evaluate effectiveness of distal embolic protection compared to abciximab administration in reduction of microembolic complications of primary coronary angioplasty. Ochała A; Smolka G; Wojakowski W; Gabrylewicz B; Garbocz P; Tendera M Kardiol Pol; 2007 Jun; 65(6):672-80; discussion 681-3. PubMed ID: 17629829 [TBL] [Abstract][Full Text] [Related]
18. Effect of abciximab on myocardial salvage in patients with acute myocardial infarction undergoing primary angioplasty. Lee CW; Moon DH; Hong MK; Lee JH; Choi Si; Yang HS; Kim JJ; Park SW; Park SJ Am J Cardiol; 2002 Dec; 90(11):1243-6. PubMed ID: 12450607 [No Abstract] [Full Text] [Related]
19. [Subacute intracoronary stent thrombosis in a patient with polycythaemia vera]. Hvelplund A; Hansen PR Ugeskr Laeger; 2006 Nov; 168(47):4104-5. PubMed ID: 17134610 [TBL] [Abstract][Full Text] [Related]
20. Interventional therapy for coronary artery disease. Shah PB; Lilly CM Am J Respir Crit Care Med; 2002 Sep; 166(6):791-6. PubMed ID: 12231486 [No Abstract] [Full Text] [Related] [Next] [New Search]